One of the biggest challenges in health care is the fight against tumo
rs. Some phenothiazines have antitumor activity on HEp-2 tumor cells.
In this study, we tested the antitumor effects of three series such as
10-nonsubstituted phenothiazines, hthalimido)alkyl]-2-substituted-10H
-phenothiazines and 2-substituted-10H-phenothiazin-10-yl)alkyl-1-ureas
with H, Cl and CF3 substitution at position C2. The TCID50 of phenoth
iazines was affected by the H, Cl and CF3 at C2. Trifluoromethyl deriv
ative of phenothiazine showed potent (R=CF3, TCID50=4.7 mu g) activity
, whereas the chlorine derivative of phenothiazine (R=Cl, TCID50=62.5
mu g) had a relatively weak effect. In the group of thalimido)alkyl]-2
-substituted-10H-phenothiazines, 10-[3-(phthalimido)propyl]-10H-phenot
hiazine (R=H, n=3, TCID50=11.5 mu g), was very effective. On the other
hand, TCID50 of [3-(phthalimido)propyl]-2-chloro-10H-phenothiazine (R
=Cl, n=3, TCID50=75.0 mu g), -[4-(phthalimido)butyl]-2-chloro-10H-phen
othiazine (R=Cl, n=4, TCID50=31.3 mu g) and alimido)butyl]-2-trifluoro
methyl-10H-phenothiazine (R=CF3, n=4, TCID50=50.0 mu g) were about 4-8
times less effective than 10-[4-(phthalimido)butyl]-10H-phenothiazine
(R=H, n=4, TCID50=7.8 mu g). Among six -substituted-10H-phenothiazin-
10-yl)alkyl-1-ureas, two chlorine compounds such as )-3-(2-chloro-10H-
phenothiazin-10-yl)propyl-1-urea (R=Cl, n=3, TCID50=7.8 mu g), and rif
luoromethyl-10H-phenothiazin-10-yl)butyl-1-urea (R=CF3, n=4, TCID50=7.
8 mu g) were significantly active. Tests showed that the substitution
at 2C position apparently affected the anti-HEp-2 tumor cell activity;
that the length of the aliphatic side chain at 10N contributes to the
anti-tumor activity; and that the TCID50 values of the derivatives wi
th butylene group (-C4H8-) were lower than those with propylene group
(-C3H6-) except 10-[4-(phthalimido) butyl]-2-trifuoromethyl-10H-phenot
hiazine and -chloroethyl)-3-(2-chloro-10H-pheno-thiazin-10-yl) butyl-1
-urea.